Explore evidence

47.1 %The prevalence of hypoxemia among SCA participants was 47.1%.

Nigeriadrépanocytose · hypoxaemiapublished 2024BMC research notesPubMeddocument of 3 observations

64.1 %Among 209 parents of children with SCD in Ibadan, Nigeria, 64.1% had moderate knowledge of SCD, 20.6% had good knowledge, and 15.3% had poor knowledge.

Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 5 observations

40,000 personsThe Sickle Pan-African Research Consortium (SPARCo) registry includes data from over 40,000 persons living with sickle cell disease in seven African countries.

Ghana · Mali · Nigeria · Ouganda · Tanzanie · Zambie · Zimbabwedrépanocytosepublished 2026Database : the journal of biological databases and curationeurope_pmc

7.7 g/dLThe mean ± SD haemoglobin level was 7.7 ± 1.5 g/dL for pediatric sickle cell anaemia patients in steady state.

Nigeriadrépanocytoseobserved 2023published 2025BMC pediatricsPubMeddocument of 16 observations

36.8 %In a cross-sectional study of 405 Nigerian children, 36.8% were heterozygous for alpha+-thalassaemia.

Nigeriadrépanocytosepublished 2001Tropical medicine & international health : TM & IHeurope_pmcdocument of 8 observations

74 %Seventy-four percent of the respondents noted that hydroxyurea improved overall quality of life of patients with sickle cell disease.

Nigeriadrépanocytosepublished 2019HemoglobinPubMeddocument of 7 observations

All participants with abnormal transcranial Doppler velocities were started on hydroxyurea.

Nigeriadrépanocytosepublished 2022Journal of pediatric hematology/oncologyPubMeddocument of 5 observations

19.3 %The overall prevalence of the C677T mutation among participants was 19.3% (37 of 192).

Nigeriadrépanocytosepublished 2019The Pan African medical journalPubMeddocument of 2 observations

26 %The median haematocrit increased from 26% to 28% after 12 months of hydroxyurea therapy.

Nigeriadrépanocytosepublished 2020Journal of tropical pediatricsPubMeddocument of 4 observations

44 %In a cross-sectional study of 405 Nigerian children, 44% were alpha+-thalassaemic.

Nigeriadrépanocytosepublished 2001Tropical medicine & international health : TM & IHeurope_pmcdocument of 8 observations

52.4 %The spleen was visualised in 107 (52.4%) patients with sickle cell disease on ultrasonography.

Nigeriadrépanocytosepublished 2023Tropical medicine & international health : TM & IHPubMeddocument of 6 observations

7 yearsThe median duration of pentazocine abuse or self-use among participants was 7 years.

Nigeriadrépanocytosepublished 2019The Pan African medical journalPubMeddocument of 2 observations

26.7 %Acute chest syndrome accounted for 26.7% of respiratory morbidities among sickle cell disease patients.

Nigeriadrépanocytose · syndrome thoracique aigu (drépanocytose)observed 2012 to 2021published 2024PloS onePubMeddocument of 12 observations

27 %Wasting (body mass index z-score<-2) had a prevalence of 27% in Nigerian patients.

Nigeriadrépanocytosepublished 2019ThoraxPubMeddocument of 7 observations

98.8 %After a health education session, 98.8% of pregnant women understood that a blood test is the right way to know if one has sickle cell disease, compared to 78.7% before the session.

Nigeriadrépanocytosepublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations

100 %For HbAC phenotype, isoelectric focusing showed a sensitivity of 100%.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations

100 %The spleen was visualised in all children less than 5 years of age with sickle cell disease.

Nigeriadrépanocytosepublished 2023Tropical medicine & international health : TM & IHPubMeddocument of 6 observations

35.4 %The prevalence of HbSS α+1 was 35.4% among sickle cell disease patients.

Nigeriadrépanocytose · HbSS α+1published 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001

44 %Pavetta crassipes at the high dose of 0.5 mg/ml caused a reduction in percentage of sickle red cells from 44.0% to 15.3% at 150 minutes.

Nigeriadrépanocytosepublished 2020West African journal of medicineeurope_pmcdocument of 3 observations

5.1 %Overweight/obesity was observed in 5.1% of subjects with sickle cell anemia.

Nigeriadrépanocytose · overweight/obesitypublished 2020Nigerian journal of clinical practicePubMeddocument of 9 observations

8 patients8 had erectile dysfunction.

Nigeriadrépanocytosepublished 2021Hematology (Amsterdam, Netherlands)PubMeddocument of 16 observations

20 %The prevalence of myocardial ischemia measuring both cardiac troponin T and electrocardiography in children with sickle cell anemia in steady state was 20%.

Nigeriadrépanocytose · myocardial ischemiaobserved 2019published 2024Journal of tropical pediatricsPubMeddocument of 6 observations

33.3 %33.3% of respondents had limited understanding of the implications of sickle cell disease.

Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 6 observations

1.2 %Standard HemoTypeSC identified 6 (1.2%) HbSS phenotypes among 511 newborns.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations

100 %The positive and negative predictive values for SS, SC, AS, AC, and AA genotypes by HemotypeSC relative to PCR were each 100%.

Nigeriadrépanocytosepublished 2021Global pediatric healtheurope_pmcdocument of 5 observations